Company Zai Lab Limited

ZLAB

US98887Q1040

Pharmaceuticals

Market Closed - Nasdaq 00:00:00 05/09/2026 +04			5-day change	1st Jan Change
26.23 ^USD	-2.85%		+3.02%	+48.70%

09-04	Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading	MT
09-02	Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT

Business description: Zai Lab Limited

Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Number of employees: 1,784

Sales by Activity: Zai Lab Limited

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Biotechnology	144M	215M	267M	399M	460M

See all business segments

Geographical breakdown of sales: Zai Lab Limited

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
People's Republic of China (PRC)	144M	-	-	399M	460M

See all geographic segments

Executive Committee: Zai Lab Limited

Manager	Title	Age	Since
Ying Du CEO	Chief Executive Officer	61	01/04/2014
Ya jing Chen DFI	Director of Finance/CFO	58	07/07/2023
Rafael Amado PSD	President	62	01/12/2022
Joshua Smiley PSD	President	56	01/04/2023
Robert Brown CTO	Chief Tech/Sci/R&D Officer	-	01/09/2023

See ZAI LAB LIMITED governance

Composition of the Board of Directors: Zai Lab Limited

Director	Title	Age	Since
Ying Du CHM	Chairman	61	01/04/2014
John Diekman BRD	Director/Board Member	83	01/01/2017
Peter Wirth BRD	Director/Board Member	75	01/01/2017
William David Lis BRD	Director/Board Member	61	01/10/2018
Lonnie Moulder BRD	Director/Board Member	68	01/01/2019
Scott Morrison BRD	Director/Board Member	68	13/10/2021
Richard Gaynor BRD	Director/Board Member	76	19/11/2021
Wing Yu Leung BRD	Director/Board Member	55	01/08/2014
Michel Vounatsos BRD	Director/Board Member	64	07/01/2023

Composition of the Board of Directors

Shareholders: Zai Lab Limited

Name	Stocks	%	Valuation
RTW Investments LP 9.032 %	10,276,998	9.032 %	262 M $
RTW Investments LP 5.778 %	6,574,032	5.778 %	167 M $
TCG Crossover Management LLC 5.394 %	6,137,627	5.394 %	156 M $
TCG Crossover Management LLC 5.394 %	6,137,627	5.394 %	156 M $
RA Capital Management LP 5.048 %	5,743,533	5.048 %	146 M $

Name	Stocks	%	Valuation
Qiming Venture Partners Ltd. 4.296 %	48,883,643	4.296 %	123 M $
Wellington Management Co. LLP 4.228 %	48,112,590	4.228 %	122 M $
Goldman Sachs & Co. LLC (Private Banking) 3.591 %	40,863,490	3.591 %	103 M $
Janus Henderson Group Ltd. 3.472 %	39,501,040	3.472 %	100 M $
Ying Du 1.715 %	19,508,280	1.715 %	49 M $

List of ZAI LAB LIMITED shareholders

Company details: Zai Lab Limited

Zai Lab Ltd.

899 Halei Road

201203, Shanghai

+86 21 6163 2588

http://www.zailaboratory.com

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZAI LAB LIMITED	-2.85%	+3.02%	-14.73%	-4.02%	2.94B
REGENERON PHARMACEUTICALS, INC.	-1.87%	+3.58%	+44.36%	+0.30%	82.65B
CSL LIMITED	+0.94%	+1.45%	-18.08%	-35.46%	59.87B
MODERNA, INC.	-2.23%	+3.71%	+478.96%	+34.33%	58.11B
SAMSUNG BIOLOGICS CO.,LTD.	+1.31%	-3.43%	-7.43%	+31.70%	50.35B
UCB	-0.76%	-4.49%	-0.81%	+152.91%	46.62B
BIOGEN INC.	-1.64%	+1.93%	+56.98%	-15.50%	32.63B
INCYTE CORPORATION	-0.98%	+2.86%	+46.30%	+99.76%	25.69B
INNOVENT BIOLOGICS, INC.	-1.09%	-1.38%	-0.30%	+161.62%	22.49B
SWEDISH ORPHAN BIOVITRUM AB	+0.87%	-0.96%	+64.13%	+108.76%	16.33B
Average	-0.83%	+0.60%	+64.94%	+53.44%	39.77B
Weighted average by Cap.	-0.74%	+1.18%	+85.62%	+40.43%